Lyndon Kim, MD

img_Lyndon Kim
PROFESSOR | Neurology
PROFESSOR | Medicine
PROFESSOR | Neurosurgery
Are you a patient?
Specialties
Cancer (Oncology)
Research Topics
Angiogenesis, Anti-Tumor Therapy, Blood-Brain Barrier, Brain, Brain Imaging, Cancer, Dendritic Cells, Drug Resistance, Genomics, Interferon, Nanotechnology, Neurology, Protein Kinases, Proteomics, Retrovirus, Seizure

MD, Yonsei University College Of Medicine

Residency, Internal Medicine, Brooklyn Hospital-Caledonian Hospital

Residency, Internal Medicine, Robert Wood Johnson University Hospital

Fellowship, Hematology & Medical Oncology, The Warren Alpert Medical School Of Brown University

Fellowship, Neuro-oncology, Massachusetts General Hospital

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial. Patrick Y. Wen, Donald A. Berry, Meredith B. Buxton, Howard Colman, John de Groot, Michael Lim, Ingo Mellinghoff, James R. Perry, Michael Weller, Nicholas A. Blondin, Omar H. Butt, Denise M. Damek, Macarena I. de la Fuente, Jan Drappatz, Erin Dunbar, Pierre Giglio, Emma Viktoria Hyddmark, Fabio Iwamoto, Kurt A. Jaeckle, Lyndon Kim, Heather M. Kling, Eudocia Q. Lee, Megan Mantica, Tom Mikkelsen, Burt Nabors, Herbert B. Newton, Jeffrey J. Olson, David Schiff, Tobias Walbert, Shiao Pei Weathers, Timothy Cloughesy, Andrew B. Lassman, Brian Alexander, Mark D. Anderson, Lars Anker, Donald A. Berry, Nicholas S. Berry, Nicholas A. Blondin, Omar H. Butt, Meredith B. Buxton, Webster K. Cavenee, Tim Cloughesy, Howard Colman, Jennifer Connelly, Denise M. Damek, John de Groot, Macarena I. de la Fuente, Michelle A. Detry, Jan Drappatz, Lyndon Kim. Journal of Clinical Oncology

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial. Patrick Y. Wen, Donald A. Berry, Meredith B. Buxton, Howard Colman, John de Groot, Michael Lim, Ingo Mellinghoff, James R. Perry, Michael Weller, Nicholas A. Blondin, Omar H. Butt, Denise M. Damek, Macarena I. de la Fuente, Jan Drappatz, Erin Dunbar, Pierre Giglio, Emma Viktoria Hyddmark, Fabio Iwamoto, Kurt A. Jaeckle, Lyndon Kim, Heather M. Kling, Eudocia Q. Lee, Megan Mantica, Tom Mikkelsen, Burt Nabors, Herbert B. Newton, Jeffrey J. Olson, David Schiff, Tobias Walbert, Shiao Pei Weathers, Timothy Cloughesy, Andrew B. Lassman. Journal of Clinical Oncology

Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group. Nam P. Nguyen, Brandi R. Page, Huan Giap, Zineb Dahbi, Vincent Vinh-Hung, Olena Gorobets, Mohammad Mohammadianpanah, Micaela Motta, Maurizio Portaluri, Meritxell Arenas, Marta Bonet, Pedro Carlos Lara, Lyndon Kim, Fabien Dutheil, Elena Natoli, Gokoulakrichenane Loganadane, David Lehrman, Satya Bose, Sarabjot Kaur, Sergio Calleja Blanco, Alexander Chi. Cancers

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Kim has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.